LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 135 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $185,000 | -13.6% | 21,611 | 0.0% | 0.07% | -10.8% |
| Q4 2017 | $214,000 | -19.5% | 21,611 | 0.0% | 0.07% | -22.1% |
| Q3 2017 | $266,000 | -25.3% | 21,611 | 0.0% | 0.10% | -26.4% |
| Q2 2017 | $356,000 | +14.8% | 21,611 | 0.0% | 0.13% | +16.2% |
| Q1 2017 | $310,000 | +3.7% | 21,611 | 0.0% | 0.11% | -9.0% |
| Q4 2016 | $299,000 | -23.5% | 21,611 | 0.0% | 0.12% | -47.9% |
| Q3 2016 | $391,000 | +26.1% | 21,611 | 0.0% | 0.23% | +33.7% |
| Q2 2016 | $310,000 | +20.2% | 21,611 | 0.0% | 0.18% | +8.7% |
| Q1 2016 | $258,000 | -10.4% | 21,611 | 0.0% | 0.16% | -23.0% |
| Q4 2015 | $288,000 | +24.1% | 21,611 | 0.0% | 0.21% | +22.2% |
| Q3 2015 | $232,000 | +33.3% | 21,611 | 0.0% | 0.17% | +25.7% |
| Q2 2015 | $174,000 | – | 21,611 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $78,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $1,039,349,000 | 20.58% |
| NEA Management Company, LLC | 2,382,286 | $43,048,000 | 1.93% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $645,000 | 1.72% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 809,666 | $14,631,000 | 0.67% |
| MOODY ALDRICH PARTNERS LLC | 42,180 | $762,000 | 0.53% |
| Cupps Capital Management, LLC | 62,549 | $1,130,000 | 0.49% |
| BRIDGER MANAGEMENT, LLC | 336,966 | $6,089,000 | 0.41% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 258,353 | $4,668,000 | 0.34% |
| Round Table Services, LLC | 21,611 | $391,000 | 0.23% |